BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 10778157)

  • 1. [Cadherin].
    Ouchi K; Sugawara T; Fujiya T
    Nihon Rinsho; 1999 Dec; 57 Suppl():433-5. PubMed ID: 10778157
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cadherin family].
    Fujiya T; Yamanami H
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():173-5. PubMed ID: 20960770
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of correlation between serum levels of E- and P-cadherin fragments and the presence of breast cancer.
    Knudsen KA; Lin CY; Johnson KR; Wheelock MJ; Keshgegian AA; Soler AP
    Hum Pathol; 2000 Aug; 31(8):961-5. PubMed ID: 10987257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum E-cadherin concentrations and their response during laparoscopic and open cholecystectomy.
    Karayiannakis AJ; Syrigos KN; Savva A; Polychronidis A; Karatzas G; Simopoulos C
    Surg Endosc; 2002 Nov; 16(11):1551-4. PubMed ID: 12072997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of age on soluble E-cadherin serum levels prevents its utility as a disease marker in gastric cancer patients.
    Pedrazzani C; Caruso S; Corso G; Marrelli D; Neri A; Berardi A; Roviello F
    Scand J Gastroenterol; 2008; 43(6):765-6. PubMed ID: 18569997
    [No Abstract]   [Full Text] [Related]  

  • 6. sVE-cadherin and sCD146 serum levels in patients with multiple myeloma.
    Wrobel T; Mazur G; Wolowiec D; Jazwiec B; Sowinska E; Kuliczkowski K
    Clin Lab Haematol; 2006 Feb; 28(1):36-9. PubMed ID: 16430458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin.
    Chan AO; Chu KM; Lam SK; Cheung KL; Law S; Kwok KF; Wong WM; Yuen MF; Wong BC
    Cancer; 2005 Aug; 104(4):740-6. PubMed ID: 15991243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer.
    Chan AO; Chu KM; Lam SK; Wong BC; Kwok KF; Law S; Ko S; Hui WM; Yueng YH; Wong J
    J Clin Oncol; 2003 Jun; 21(12):2288-93. PubMed ID: 12805328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of blood levels of E-cadherin for diagnosis of colonic cancer].
    Sugawara Y; Ouchi K; Ono H; Kamiyama Y; Fujitani T; Kadokawa Y; Mikuni J; Yamanami H
    Nihon Geka Gakkai Zasshi; 1998 Apr; 99(4):273. PubMed ID: 9750074
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevated serum levels of soluble E-cadherin in patients with primary Sjögren's syndrome.
    Jonsson MV; Salomonsson S; Øijordsbakken G; Skarstein K
    Scand J Immunol; 2005 Dec; 62(6):552-9. PubMed ID: 16316423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
    Villasante A; Pacheco A; Pau E; Ruiz A; Pellicer A; Garcia-Velasco JA
    Hum Reprod; 2008 Mar; 23(3):662-7. PubMed ID: 18216038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum E-cadherin assay in patients with ovarian carcinoma.
    Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Ciampi B; Bianchi R; Genazzani AR
    Anticancer Res; 1999; 19(1B):769-72. PubMed ID: 10216491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short-term preoperative treatment of celecoxib, a selective cyclooxygenase-2 inhibitor, on E-cadherin expression in gastric carcinoma tissues].
    Ran JT; Zhou YN; Tang CW; Li HH; Li XW; Lu H
    Ai Zheng; 2009 Apr; 28(4):361-5. PubMed ID: 19622294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of some serum biomarkers (E cadherin, GAGs & MDA in patients with diffuse large B-cell lymphoma.
    Eissa LA; Esmaeel MI
    Pak J Pharm Sci; 2008 Jan; 21(1):29-35. PubMed ID: 18166516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of the serum level of soluble E-cadherin in patients with HCC.
    Soyama A; Eguchi S; Takatsuki M; Kawashita Y; Hidaka M; Tokai H; Nagayoshi S; Mochizuki S; Matsumoto S; Hamasaki K; Tajima Y; Kanematsu T
    Hepatogastroenterology; 2008; 55(85):1390-3. PubMed ID: 18795696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cadherins as predictive markers of nodal metastasis in breast cancer.
    Madhavan M; Srinivas P; Abraham E; Ahmed I; Mathew A; Vijayalekshmi NR; Balaram P
    Mod Pathol; 2001 May; 14(5):423-7. PubMed ID: 11353052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cadherin family].
    Fujiya T; Yamanami H; Kakukawa Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():151-3. PubMed ID: 16149475
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating soluble E-cadherin levels are of prognostic significance in patients with multiple myeloma.
    Syrigos KN; Harrington KJ; Karayiannakis AJ; Baibas N; Katirtzoglou N; Roussou P
    Anticancer Res; 2004; 24(3b):2027-31. PubMed ID: 15274395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of two mesenchymal cadherins, cadherin 11 and N-cadherin, on murine fibroblast-like synoviocytes.
    Agarwal SK; Lee DM; Kiener HP; Brenner MB
    Arthritis Rheum; 2008 Apr; 58(4):1044-54. PubMed ID: 18383368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.